查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1722975

2025 年至 2033 年基因檢測市場規模、佔有率、趨勢及預測（按類型、技術、應用和地區）

Genetic Testing Market Size, Share, Trends and Forecast by Type, Technology, Application, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球基因檢測市場規模價值 195 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 448.8 億美元，2025 年至 2033 年的複合年成長率為 9.70%。北美目前佔據市場主導地位，2024 年的市佔率將超過 45.6%。北美市場主要受到技術進步、個人化醫療需求不斷成長、遺傳疾病患病率上升、政府支持舉措的訂定以及道德、法律和社會考慮因素日益增加的影響。

基因檢測市場分析：

市場成長與規模：隨著大眾了解程度的提高和對個人化醫療的需求增加，該產業正在強勁成長。隨著檢測技術的進步，市場正以極快的速度滲透到新的醫療保健領域，並已成為醫療保健行業最具活力的領域之一。

主要市場促進因素：主要因素是新技術的引入、遺傳疾病和慢性病盛行率的增加以及消費者對遺傳風險認知的提高。政府對基因研究的舉措和資助也極大地幫助了該行業的市場成長，這為基因檢測市場有多大提供了準確的答案。

技術進步：NGS（下一代定序）和 CRISPR 技術的創新徹底改變了測試，提供了精確且經濟實惠的方法。這些發展擴大了基因檢測的範圍和機會，進而增加了其在臨床和研究中的使用。

產業應用：檢測應用包括癌症診斷、遺傳疾病診斷、心血管疾病診斷等。它可用於診斷和管理遺傳疾病，使其成為現代醫療保健不可分割的一部分。

主要市場趨勢：人們越來越傾向於直接面對消費者的服務，使用者無需醫生介入即可獲取基因資訊。市場也正在經歷一種趨勢，即檢測正在成為疾病篩檢和管理的常規醫療保健實踐的一部分，這表明基因檢測市場的未來前景樂觀。

地理趨勢：北美佔據市場主導地位，其次是歐洲和亞太地區。醫療設施、人均醫療支出、政府援助等因素也促進了這些地區的發展。儘管面臨當前挑戰，拉丁美洲、中東和非洲的新興市場仍展現出成長潛力。

競爭格局：市場競爭激烈，主要參與者從事研發、策略夥伴關係和法規遵循。這些公司正專注於擴大其測試組合併探索新的市場機會以保持其競爭優勢。

挑戰與機會：雖然市場提供了巨大的成長機會，但也面臨著測試的道德和法律影響、對熟練專業人員的需求以及公眾認知問題等挑戰。應對這些挑戰並利用技術進步為市場擴張和創新提供了重大機會。

基因檢測市場趨勢：

基因檢測技術的進步

基因檢測技術的進步對推動基因檢測市場規模的成長起到了重要作用。這些技術創新帶來了更準確、更有效率、更具成本效益的基因分析方法，將檢測範圍擴展到腫瘤學、藥物基因組學和預測測試等領域，進一步推動了基因檢測市場的成長。增強型定序技術，例如次世代定序 (NGS)，可以提供有關遺傳疾病的詳細見解，從而實現早期發現和個人化治療計劃。例如，

一項針對 1914 名女性的研究表明，與標準篩檢相比，cfDNA 檢測顯著降低了 21 三體和 18 三體的假陽性率，檢測非整倍體的成功率為 100%，且預測值更高。此外，簡化的流程增加了各種醫療保健環境中對基因檢測的採用，從而促進了基因檢測市場的需求。

個人化醫療意識和需求不斷增強

人們對個人化醫療的認知和需求不斷提高，也在塑造基因檢測市場前景方面發揮了重要作用。個人化醫療依賴基因資訊來制定治療方案，這增加了對基因檢測的需求。這種需求在腫瘤學和生殖健康等領域尤其明顯，這些領域的基因檢測可以指導治療決策並評估後代的遺傳疾病風險。例如，根據一項研究，一項回覆率為 36% 的調查顯示，在 312 名受訪者中，83% 的人對直接面對消費者的基因檢測有極少的詢問，14% 的人涉及結果解釋，超過 50% 的人支持遺傳諮詢師和臨床環境進行基因檢測的作用，70% 的人願意為有匿名檢測或訪問問題的患者。此外，消費者對了解健康狀況的遺傳傾向的興趣日益濃厚，進一步推動了基因檢測市場概況，推動了基因檢測市場統計數據和基因檢測市場趨勢。

遺傳性疾病和慢性病增多

全球遺傳疾病和慢性病的增加進一步推高了基因檢測市場的數據。基因檢測在囊性纖維化、鐮狀細胞性貧血和亨廷頓氏病等各種疾病的早期發現、診斷和管理中發揮著至關重要的作用。此外，隨著癌症、心血管疾病和糖尿病等慢性疾病發生率的不斷上升，人們越來越需要進行檢測，以識別導致個人患有這些疾病的基因突變。世界衛生組織 (WHO) 報告稱，癌症、心血管疾病和糖尿病等非傳染性疾病 (NCD) 每年造成全球 73% 的死亡。基因檢測可以幫助識別患有這些疾病的風險個體。透過檢測進行早期發現可以改善患者的治療效果，進一步推動基因檢測市場的發展。基因檢測市場規模龐大，美國等已開發國家每年的基因檢測數量都有顯著成長。展望未來，基因檢測前景光明，預計持續的技術進步將提高準確性和可及性。懷孕期間的基因檢測也變得越來越普遍，為胎兒健康和遺傳狀況提供了寶貴的見解。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球基因檢測市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 預測性和症狀前檢測
  • 攜帶者檢測
  • 產前和新生兒檢測
  • 診斷測試
  • 藥物基因組學檢測
  • 其他

第7章：市場區隔：依技術

  • 細胞遺傳學檢測和染色體分析
  • 生化檢測
  • 分子檢測
    • 關鍵部分
      • DNA定序
      • 其他

第 8 章：市場區隔：按應用

  • 癌症診斷
  • 遺傳疾病診斷
  • 心血管疾病診斷
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 23andme Inc.
    • Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
    • Bio-RAD Laboratories Inc.
    • Cepheid (Danaher Corporation)
    • Eurofins Scientific
    • Illumina Inc.
    • Invitae Corporation
    • Luminex Corporation (DiaSorin)
    • Myriad Genetics Inc.
    • QIAGEN
    • Quest Diagnostics
    • Thermo Fisher Scientific
Product Code: SR112025A5788

The global genetic testing market size was valued at USD 19.5 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 44.88 Billion by 2033, exhibiting a CAGR of 9.70% from 2025-2033. North America currently dominates the market, holding a market share of over 45.6% in 2024. The North American market is primarily driven by technological advancements, escalating demand for personalized medicine, rising prevalence of genetic disorders, introduction of supportive government initiatives, and increasing implication of ethical, legal, and social considerations.

Genetic Testing Market Analysis:

Market Growth and Size: The sector is seeing strong growth as the public becomes more informed and the appetite for personalized medicine increases. With advancements in testing technologies, the market is penetrating new healthcare sectors at an extremely rapid pace and has become one of the most dynamic segments of the healthcare industry.

Major Market Drivers: The main factors are the introduction of new technologies, the increase in the prevalence of genetic diseases and chronic conditions and the increasing of the consumer's knowledge about genetic risks. Government initiatives and funding of genetic research also greatly assist the industry in market growth, which provide an accurate answer to how big is the genetic testing market.

Technological Advancements: Innovations in NGS (next-generation sequencing) and CRISPR technologies have revolutionized testing providing precise and budget-friendly methods. These developments have enlarged the range and opportunity of genetic testing, which in turn has increased the usage of it both in clinical settings and in research.

Industry Applications: The application of the testing includes cancer diagnosis, genetic disease diagnosis, and cardiovascular disease diagnosis. It can be used for diagnosing and managing genetic diseases makes it an inseparable part of modern healthcare.

Key Market Trends: There is a rising preference for direct-to-consumer services, in which users can acquire genetic information without using an intervening doctor. The market is also experiencing a trend where testing is becoming part of regular healthcare practices for disease screening and management, which indicates a positive outlook for the future of genetic testing market.

Geographical Trends: North America dominates the market, followed by Europe and the Asia Pacific. Factors including healthcare facilities, per capita medical expenditure, and governmental assistance also contribute to the development of these regions. Emerging markets in Latin America and the Middle East and Africa show potential for growth despite current challenges.

Competitive Landscape: The market is highly competitive with key players engaging in research and development, strategic partnerships, and regulatory compliance. These companies are focusing on expanding their testing portfolios and exploring new market opportunities to maintain their competitive edge.

Challenges and Opportunities: While the market offers substantial growth opportunities, it faces challenges such as ethical and legal implications of testing, the need for skilled professionals, and public perception issues. Addressing these challenges and harnessing technological advancements present significant opportunities for market expansion and innovation.

Genetic Testing Market Trends:

Advancements in genetic testing technologies

Advancements in genetic testing technologies have been instrumental in driving the genetic testing market size. These technological innovations have led to more accurate, efficient, and cost-effective genetic analysis methods, expanding the scope of testing into areas such as oncology, pharmacogenomics, and predictive testing, further driving the genetic testing market growth. Enhanced sequencing techniques, such as next-generation sequencing (NGS), provide detailed insights into genetic disorders, enabling early detection and personalized treatment plans. For instance,

A study on 1914 women revealed cfDNA testing significantly reduces false positives for trisomies 21 and 18 compared to standard screening, with a 100% success rate in detecting aneuploidies and higher predictive values. Furthermore, simplified processes have increased the adoption of genetic testing across various healthcare settings, contributing to the genetic testing market demand.

Increasing awareness and demand for personalized medicine

Increasing awareness and demand for personalized medicine have also played a significant role in shaping the genetic testing market outlook. Personalized medicine, which relies on genetic information to tailor treatments, has heightened the demand for genetic tests. This demand is particularly evident in sectors such as oncology and reproductive health, where genetic testing guides therapy decisions and assesses genetic disorder risks in offspring. For example, according to a study, survey with a 36% response rate showed that 83% of the 312 respondents had minimal inquiries about direct-to-consumer genetic testing, 14% dealt with result interpretation, and over 50% supported the role of genetic counsellors and clinical settings for genetic testing, with 70% open to considering it for patients with privacy, anonymity, or access concerns. Additionally, growing consumer interest in understanding genetic predispositions to health conditions further fuels genetic testing market overview, driving genetic testing market statistics and genetic testing market trends.

Rise in genetic disorders and chronic diseases

The rise in genetic disorders and chronic diseases globally is further escalating the genetic testing market statistics. Genetic testing plays a vital role in the early detection, diagnosis, and management of various conditions such as cystic fibrosis, sickle cell anemia, and Huntington's disease. Moreover, with the increasing incidence of chronic diseases, including cancer, cardiovascular diseases, and diabetes, there is a heightened need for testing to identify genetic mutations predisposing individuals to these conditions. The World Health Organization (WHO) reports that non-communicable diseases (NCDs), such as cancer, cardiovascular diseases, and diabetes, are responsible for 73% of global deaths annually. Genetic testing can help identify individuals at risk for these conditions. Early detection through testing improves patient outcomes, further propels the genetic testing market. The genetic testing market is substantial, with a considerable growth in the number of genetic testing per year in USA and other developed countries. Looking ahead, the future of genetic testing is promising, with continued technological advancements expected to enhance accuracy and accessibility. Genetic testing in pregnancy is also becoming increasingly prevalent, providing valuable insights into fetal health and genetic conditions.

Genetic Testing Industry Segmentation:

Breakup by Type:

  • Predictive and Presymptomatic Testing
  • Carrier Testing
  • Prenatal and Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • Others

Diagnostic testing accounts for the majority of the market share

The largest sector of the market is the diagnostic testing market, which is employed to reveal or confirm specific inherited disease in symptomatic people. This sector is on the rise due to its contribution to a precise diagnosis, which is necessary for appropriate treatment and control of a plethora of genetic conditions. The fact of its broad fields of using from rare genetical diseases till common conditions brings attention to this issue in medical sector. An investigation that appeared in the Journal of Molecular Diagnostics revealed that the percentage of medical professionals who had integrated genetic diagnostic testing for hereditary cancers definitely had grown from 19.8% in 2014 to 38.4% in 2018.

Breakup by Technology:

  • Cytogenetic Testing and Chromosome Analysis
  • Biochemical Testing
  • Molecular Testing
  • DNA Sequencing
  • Others

Molecular testing holds the largest share in the industry

Molecular testing represents the largest section in the market. The methodology portion cover PCR, NGS, and other filtered DNA related analysis terms. It is very practical as it can be applied for many sections, from detecting genetic changes that give rise to diseases, to exploring cancer genetics for the reason of targeted treatments, and to unearthing genetic predispositions for different conditions. The unique capability of molecular testing associated with the precision it offers has established the field of genetic diagnostics, individualized medicine, and research as a key area in molecular science, giving it a leading position in this field. A 2021 study evaluated various COVID-19 molecular tests, revealing a high sensitivity rate of 95.9% for minimizing false negatives, and a specificity rate of 97.2% to reduce false positives. Besides, cytogenetic testing, including chromosome analysis means looking through section of chromosome in attempted to get information about chromosomal abnormalities of the patient. This part has a vital role in recognition the chromosome count, missing only one chromosome could cause genetic disorders such as Down syndrome, Klinefelter syndrome or Turner syndrome. It is widely use in pre-natal testing, cancer diagnosis and also for studying cells chromosome change, which are hardly beyond disease.

The biochemical testing, on the other hand, is directed towards the measurement of the exact amount of activity in most cases of specific enzymes in the body or the levels of proteins, hormones and other substances that comprise the body. This segment is a vital step in identifying metabolic disorders that result from enzyme deficiency by determining conditions like PKU or Tay- Sachs Disease, as possible causes.

Breakup by Application:

  • Cancer Diagnosis
  • Genetic Disease Diagnosis
  • Cardiovascular Disease Diagnosis
  • Others

Genetic disease diagnosis represents the leading market segment

Genetic testing is currently utilized to diagnose a large number of diseases that are affected by both single-gene and multiple-gene factors. Genetic disease diagnosis is essential for the early detection of diseases and prompt intervention that finally aid in the condition's management. This growth is powered by its rear-rooted importance in the field of medicine which is represented in the accurate diagnoses of the genetic diseases not only for treatment but also for family planning. Between 2012 and 2022, the US led in the expansion of genetic tests, primarily for clinical diagnosis, highlighting the need for mandatory reporting and international collaboration for a comprehensive understanding of global genetic testing.

Using genetic analysis for cancer diagnosis implies finding out genetic mutations or alterations which cause cancer to develop. This portion is very vital for early tumor detection, diagnosis and controlling different categories of cancer.

Moreover, the genetic diagnosis of cardiovascular diseases involves locating these genetic variants to establish an increased risk for such heart-related defects as congenital heart defects, various cardiomyopathies, and arrhythmias.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America leads the market, accounting for the largest genetic testing market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America is the largest segment in the world market, driven by the world class healthcare infrastructure, the high amount of money that is spent on the healthcare sector and the presence of top companies and research institutions. The region is propelled by strong private investment, in the field of personalized medicine, large investments by governments in gene research, and favorable policy decisions from the national government. Besides, genetic disorders as well as chronic diseases, with a growing number of patients and informed population ready to access testing services, boost propel this company's leading position in the market.

The European region remains of crucial importance in terms of the market structure which is based on well-developed healthcare systems and governmental financial support of genetic research. The locale's market growth is propelled by the growing awareness about genetic DNA, personalized medicine, and the availability of qualified personnel in the field of genetics.

The Asia Pacific region is experiencing a growing market come from the fact that it is a large population base, infrastructure on healthcare rising and increasing the expenditure on healthcare. The market also draws support from genetic disease awareness growth, personalized medicine demanded growth, and government initiatives in health care reform.

The Latin American market is developing steadily, it is stimulated by improvement of the healthcare infrastructure, by the growth of the wages, and by the increase in public health awareness. As region is faced with the increasing demand for testing services for diseases prevention, diagnosis, and treatment.

The middle east and Africa market holds a lot of promise of significant growth. Factors that include the rising number of healthcare expenditure, the growing prevalence of genetic diseases, as well as the heightened level of awareness of the significant effects of genetic testing across the industry are the major drivers of genetic testing in this part of the world.

Leading Key Players in the Genetic Testing Industry:

Market's key players adopt different strategies to achieve fundamental objective of strengthening their market share. This include is investing heavily in research and development to innovation and evolution of genetic testing technologies, especially in the direction of next-generation sequencing (NGS) and CRISPR. They also engage in the establishment of partnerships and collaboration with other biotech companies, academic institutions, as well as healthcare providers to help them grow in their services portfolio and geographical reach. Besides this, manufacturers are making efforts to get the new devices approved by the regulator agencies to be in compliance with regulations and guarantee the patient safety. Additionally, direct-to-consumer services have been developed with the aim of leveraging consumers' growing demand for personalized healthcare and genetic wellness.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • 23andme Inc.
  • Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
  • Bio-RAD Laboratories Inc.
  • Cepheid (Danaher Corporation)
  • Eurofins Scientific
  • Illumina Inc.
  • Invitae Corporation
  • Luminex Corporation (DiaSorin)
  • Myriad Genetics Inc.
  • QIAGEN
  • Quest Diagnostics
  • Thermo Fisher Scientific

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

11 July 2023: Quest Diagnostics launched Consumer-Initiated Genetic Test on questhealth.com to Deliver Personalized, Actionable Health Risk Insights. The new offering helps people understand their potential risk of developing certain inheritable health conditions, with advanced technology and end-to-end support that includes personalized health reports and access to genetic counseling.

14 April 2023: QIAGEN launched the Applied Biosystems QuantStudio Absolute Q Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results within 90 minutes.

10 March 2022: Thermo Fisher Scientific introduced latest generation of SeqStudio Flex Series Genetic Analyzer to enable customer's cutting-edge research in areas such as gene editing and infectious disease.

Key Questions Answered in This Report

  • 1.What is genetic testing?
  • 2.How big is the genetic testing market?
  • 3.What is the expected growth rate of the global genetic testing market during 2025-2033?
  • 4.What are the key factors driving the global genetic testing market?
  • 5.What is the leading segment of the global genetic testing market based on type?
  • 6.What is the leading segment of the global genetic testing market based on technology?
  • 7.What is the leading segment of the global genetic testing market based on application?
  • 8.What are the key regions in the global genetic testing market?
  • 9.Who are the key players/companies in the global genetic testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genetic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Predictive and Presymptomatic Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Carrier Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Prenatal and Newborn Testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Diagnostic Testing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Pharmacogenomic Testing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Cytogenetic Testing and Chromosome Analysis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biochemical Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Molecular Testing
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 DNA Sequencing
      • 7.3.2.1 Others
    • 7.3.3 Market Forecast

8 Market Breakup by Application

  • 8.1 Cancer Diagnosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Genetic Disease Diagnosis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cardiovascular Disease Diagnosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 23andme Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cepheid (Danaher Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Eurofins Scientific
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Illumina Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Invitae Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Luminex Corporation (DiaSorin)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Myriad Genetics Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 QIAGEN
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Quest Diagnostics
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Genetic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Genetic Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Genetic Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Genetic Testing Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Genetic Testing Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Genetic Testing Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Genetic Testing Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Genetic Testing (Carrier Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Genetic Testing (Carrier Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Genetic Testing (Prenatal and Newborn Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Genetic Testing (Prenatal and Newborn Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Genetic Testing (Diagnostic Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Genetic Testing (Diagnostic Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Genetic Testing (Pharmacogenomic Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Genetic Testing (Pharmacogenomic Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Genetic Testing (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Genetic Testing (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Genetic Testing (Biochemical Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Genetic Testing (Biochemical Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Genetic Testing (Molecular Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Genetic Testing (Molecular Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Genetic Testing (Cancer Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Genetic Testing (Cancer Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Genetic Testing (Genetic Disease Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Genetic Testing (Genetic Disease Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Genetic Testing (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Genetic Testing (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia-Pacific: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Genetic Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Genetic Testing Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: Genetic Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: Genetic Testing Industry: SWOT Analysis
  • Figure 84: Global: Genetic Testing Industry: Value Chain Analysis
  • Figure 85: Global: Genetic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genetic Testing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Genetic Testing Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Genetic Testing Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Genetic Testing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Genetic Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Genetic Testing Market: Competitive Structure
  • Table 7: Global: Genetic Testing Market: Key Players